Purchase Order HHSD2142016M91032P
Award Date 7/26/16
Potential Completion Date 8/31/16
Potential Value $132K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq sequencer and MiniSeq system equipment. The total ceiling value of the contract is $144,985.50, with a period of performance ending on May 9, 2016. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and related products to support research and diagnostics at various...
- This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq system, a DNA sequencing instrument, at a ceiling value of $95,931.00. The contract does not have a set-aside designation. Illumina has previously been awarded other prime federal contracts and sub-grants to provide sequencing...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for a MiSeq System, sequencing instrument and associated services. The contract has a ceiling value of $97,020.00 and was awarded on April 13, 2022, with a completion date of July 1, 2022. This contract was not set aside for a specific business type. Illumina is a for-profit manufacturer of genomic sequencing and analysis products, and has experience providing...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $77,888.22 and will support the delivery of HI-/MI-SEQ KITS with a period of performance ending on September 30, 2016. The contract does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies such...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $75,775.80 contract is for the provision of Illumina MiSeq reagents to support the agency's genomic sequencing and analysis needs. The contract has no set-aside designation. Illumina has previously provided a range of sequencing systems, consumables, and services to support...
- This is a firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract, valued at $80,865.64, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to support the CDC's genomic research and analysis needs. This order is placed under the broader ILLUMINA BOA contract vehicle, which is an...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing and array-based analysis systems. The $42,553.12 contract is for a MiSeq Silver and iSeq 100 service agreement covering the period from September 15, 2022 to September 15, 2023. The award does not have a set-aside designation. Illumina has a history of providing sequencing platforms, reagents, and maintenance services to support genomic...
- This $96,401.25 firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract is for the provision of a MiSeq DNA sequencing system and does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the NIH, USDA, VA, and others for sequencing systems, reagents, and...